Skip to main content

Table 3 Prediction of N–S Research Collaboration Focusing on HIV/AIDS

From: Factors associated with North–South research collaboration focusing on HIV/AIDS: lessons from ClinicalTrials.gov

Effect

AOR

95% CI

Number of PIs

   

 Multiple vs. single

2.04**

1.32

3.14

Size of collaboration

   

 3 + institutions vs. single

4.78***

2.99

7.63

 2 institutions vs. single

1.71**

1.16

2.53

Study location

   

 3 + locations vs. 1 location

1.86**

1.18

2.92

 2 + locations vs. 1 location

1.58

0.89

2.81

Study size

   

 Large vs. small

1.97*

1.16

3.34

 Medium vs. small

0.96

0.59

1.56

Funding Source

   

 Federal vs industry only

4.45**

1.80

11.00

 Other vs industry only

0.23***

0.14

0.39

Study design

   

 RCTs vs observational

1.11

0.70

1.76

Gender

   

 Mixed vs male

1.45

0.69

3.06

 Female vs male

5.06**

2.05

12.49

Age

   

 Child vs adult

3.13**

1.43

6.86

 Mixed vs adult

2.04**

1.19

3.50

Duration of study

   

 Long vs short

1.60

0.83

3.07

 Medium vs. short

1.31

0.90

1.91

  1. *p < 0.05, ** p < 0.01, *** p < 0.001